Serological Correlate of Protection against Norovirus‐Induced Gastroenteritis
Top Cited Papers
Open Access
- 15 October 2010
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 202 (8), 1212-1218
- https://doi.org/10.1086/656364
Abstract
Background. Norovirus infection is the leading cause of acute nonbacterial gastroenteritis. Histoblood group antigens (HBGAs) are host susceptibility determinants for Norwalk virus (NV) infection. We hypothesized that antibodies that block NV-HBGA binding are associated with protection from clinical illness following NV exposure. Methods. We developed an HBGA blocking assay to examine the ability of human serum to block the interaction of NV viruslike particles with H type 1 and H type 3 glycans. Serum samples from persons who were experimentally challenged with NV were evaluated. Results. There was a high correlation between the H type 1 and H type 3 synthetic glycan assays (r=0.977; P<.001); the H type 1 assay had higher quantitative sensitivity (P<.001). Among 18 infected secretor-positive individuals, blocking titers peaked by day 28 after challenge and were higher for individuals who did not develop gastroenteritis than for those who developed gastroenteritis on days 0, 14, 28, and 180 (P<.05 for each). In addition, 6 of 6 subjects without gastroenteritis had measurable prechallenge blocking titers (>25), compared with 2 of 12 subjects with gastroenteritis (P=.002). Conclusions. Blocking antibodies correlate with protection against clinical NV gastroenteritis. This knowledge will help guide the evaluation of new vaccine strategies and the elucidation of the nature of immunity to the virus. Trial registration. ClinicalTrials.gov identifier: NCT00138476.Keywords
This publication has 29 references indexed in Scilit:
- Norovirus disease: changing epidemiology and host susceptibility factorsTrends in Microbiology, 2004
- Human susceptibility and resistance to Norwalk virus infectionNature Medicine, 2003
- Norwalk Virus-Like Particle Hemagglutination by Binding to H Histo-Blood Group AntigensJournal of Virology, 2003
- Binding of Norwalk Virus-Like Particles to ABH Histo-Blood Group Antigens Is Blocked by Antisera from Infected Human Volunteers or Experimentally Vaccinated MiceJournal of Virology, 2002
- Norwalk Virus Infection and Disease Is Associated with ABO Histo–Blood Group TypeThe Journal of Infectious Diseases, 2002
- Expression and Self-Assembly of Norwalk Virus Capsid Protein from Venezuelan Equine Encephalitis Virus RepliconsJournal of Virology, 2002
- Evidence of Immunity Induced by Naturally Acquired Rotavirus and Norwalk Virus Infection on Two Remote Panamanian IslandsThe Journal of Infectious Diseases, 1985
- Serological Responses among Teenagers after Natural Exposure to Norwalk VirusThe Journal of Infectious Diseases, 1984
- Acquisition of Serum Antibody to Norwalk Virus and Rotavirus and Relation to Diarrhea in a Longitudinal Study of Young Children in Rural BangladeshThe Journal of Infectious Diseases, 1982
- Clinical Immunity in Acute Gastroenteritis Caused by Norwalk AgentThe New England Journal of Medicine, 1977